117 related articles for article (PubMed ID: 19476571)
1. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions.
Taveira TH; Pirraglia PA; Cohen LB; Wu WC
Prev Cardiol; 2008; 11(4):195-200. PubMed ID: 19476571
[TBL] [Abstract][Full Text] [Related]
2. Successful cardiovascular risk reduction in Type 2 diabetes by nurse-led care using an open clinical algorithm.
Woodward A; Wallymahmed M; Wilding J; Gill G
Diabet Med; 2006 Jul; 23(7):780-7. PubMed ID: 16842484
[TBL] [Abstract][Full Text] [Related]
3. Risk of stroke, heart attack, and diabetes complications among veterans with spinal cord injury.
Banerjea R; Sambamoorthi U; Weaver F; Maney M; Pogach LM; Findley T
Arch Phys Med Rehabil; 2008 Aug; 89(8):1448-53. PubMed ID: 18674979
[TBL] [Abstract][Full Text] [Related]
4. [Cardiovascular effects of oral hypoglycemie drugs].
Herrmann BL; Erbel R; Janssen OE; Mann K
Herz; 2004 Aug; 29(5):510-8. PubMed ID: 15340737
[TBL] [Abstract][Full Text] [Related]
5. Maintenance of risk factor control in diabetic patients with and without mental health conditions after discharge from a cardiovascular risk reduction clinic.
Cohen LB; Taveira TH; Wu WC; Pirraglia PA
Ann Pharmacother; 2010; 44(7-8):1164-70. PubMed ID: 20501890
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
7. Outcome evaluation of a structured educational wellness program in patients with severe mental illness.
Lindenmayer JP; Khan A; Wance D; Maccabee N; Kaushik S; Kaushik S
J Clin Psychiatry; 2009 Oct; 70(10):1385-96. PubMed ID: 19778494
[TBL] [Abstract][Full Text] [Related]
8. Two-year results of paclitaxel-eluting stents in patients with medically treated diabetes mellitus from the TAXUS ARRIVE program.
Lasala JM; Cox DA; Morris DL; Breall JA; Mahoney PD; Horwitz PA; Shaw D; Hood KL; Mandinov L; Dawkins KD
Am J Cardiol; 2009 Jun; 103(12):1663-71. PubMed ID: 19539073
[TBL] [Abstract][Full Text] [Related]
9. Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype.
Blum S; Milman U; Shapira C; Miller-Lotan R; Bennett L; Kostenko M; Landau M; Keidar S; Levy Y; Khemlin A; Radan A; Levy AP
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):e18-20. PubMed ID: 18296583
[No Abstract] [Full Text] [Related]
10. Maintenance of improved lipid levels following attendance at a cardiovascular risk reduction clinic: a 10-year experience.
Pearson GJ; Olson KL; Panich NE; Majumdar SR; Tsuyuki RT; Gilchrist DM; Damani A; Francis GA
Vasc Health Risk Manag; 2008; 4(5):1127-35. PubMed ID: 19183763
[TBL] [Abstract][Full Text] [Related]
11. Do diabetes drugs modify the risk of pancreatic cancer?
Yang YX
Gastroenterology; 2009 Aug; 137(2):412-5. PubMed ID: 19563838
[No Abstract] [Full Text] [Related]
12. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn's disease.
Picco MF; Zubiaurre I; Adluni M; Cangemi JR; Shelton D
Am J Gastroenterol; 2009 Nov; 104(11):2754-9. PubMed ID: 19584832
[TBL] [Abstract][Full Text] [Related]
13. Contemporary approaches for cardiovascular risk reduction in diabetes.
Deedwania P
Indian Heart J; 2009; 61(1):24-33. PubMed ID: 19729685
[No Abstract] [Full Text] [Related]
14. Pharmacist-led cardiac risk reduction model.
Taveira TH; Wu WC; Martin OJ; Schleinitz MD; Friedmann P; Sharma SC
Prev Cardiol; 2006; 9(4):202-8. PubMed ID: 17085982
[TBL] [Abstract][Full Text] [Related]
15. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
[TBL] [Abstract][Full Text] [Related]
16. [Factors of cardiovascular risk for hypertensive patients followed during primary care].
Ben Abdelaziz A; Elrafei W; Gaha K; Mandhouj O; Ben Othman A; Ghannem H
Tunis Med; 2008 Jul; 86(7):643-8. PubMed ID: 19472724
[TBL] [Abstract][Full Text] [Related]
17. Initiative for a new diabetes therapeutic approach in a Mediterranean country: the INDEED study.
Athyros VG; Hatzitolios A; Karagiannis A; Didangelos TP; Iliadis F; Dolgyras S; Vosnakidis T; Vasiliadis P; Malias I; Tziomalos K; Samouilidou M; Mikhailidis DP;
Curr Med Res Opin; 2009 Aug; 25(8):1931-40. PubMed ID: 19558210
[TBL] [Abstract][Full Text] [Related]
18. Obesity, cardiovascular disease and type 2 diabetes in people with a mental illness: a need for primary health care.
Stanley SH; Laugharne JD
Aust J Prim Health; 2012; 18(3):258-64. PubMed ID: 23069370
[TBL] [Abstract][Full Text] [Related]
19. Interventions to maintain cardiac risk control after discharge from a cardiovascular risk reduction clinic: a randomized controlled trial.
Taveira TH; Wu WC
Diabetes Res Clin Pract; 2014 Sep; 105(3):327-35. PubMed ID: 24969964
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation.
Majhail NS; Challa TR; Mulrooney DA; Baker KS; Burns LJ
Biol Blood Marrow Transplant; 2009 Sep; 15(9):1100-7. PubMed ID: 19660723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
